ClinicoEconomics and Outcomes Research

https://www.dovepress.com/clinicoeconomics-and-outcomes-research-archive29

List of Papers (Total 325)

Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain

Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain Erin Johansson,1 Mercedes Nuñez,2 Axel Svedbom,1 Tatiana Dilla,2 Susanne Hartz3 1Access, Commercialisation & Communications, ICON plc, Stockholm, Sweden; 2Health Outcomes and Real World Evidence, Eli Lilly, Madrid, Spain; 3Global Patient Outcomes and Real World...

Impact of comorbidity on the risk and cost of hospitalization in HIV-infected patients: real-world data from Abruzzo Region [Corrigendum]

Impact of comorbidity on the risk and cost of hospitalization in HIV-infected patients: real-world data from Abruzzo Region [Corrigendum] Cammarota S, Citarella A, Manzoli L, Flacco ME, Parruti G. Clinicoecon Outcomes Res. 2018;10:389–398.Page 393, Table 2, CCI scorec (vs 0), ≥2 row, the values for the Unadjusted IRR and Adjusted IRR columns are incorrect,the data “2.32 (1.79–3...

Multiple sclerosis patients who are stable on interferon therapy show better outcomes when staying on same therapy than patients who switch to another interferon

Multiple sclerosis patients who are stable on interferon therapy show better outcomes when staying on same therapy than patients who switch to another interferon Chao Chen,1 Ning Wu,2 Crystal Watson2 1Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA; 2Value and Access, Biogen, Cambridge, MA, USA Background: Real-world outcomes...

Sacroiliac joint fusion health care cost comparison prior to and following surgery: an administrative claims analysis

Sacroiliac joint fusion health care cost comparison prior to and following surgery: an administrative claims analysis Erin K Buysman,1 Rachel Halpern,1 David W Polly2,3 1Health Economics and Outcomes Research, Optum, Eden Prairie, MN, USA; 2Department of Orthopedic Surgery, University of Minnesota, Minneapolis, MN, USA; 3Department of Neurosurgery, University of Minnesota...

Societal costs due to meningococcal disease: a national registry-based study

Societal costs due to meningococcal disease: a national registry-based study Nina Gustafsson,1 Sandra Elkjær Stallknecht,1 Mette Skovdal,2 Peter Bo Poulsen,3 Lars Østergaard4 1Incentive, Holte, Denmark; 2Vaccines, Pfizer Denmark, Ballerup, Denmark; 3Health and Value, Pfizer Denmark, Ballerup, Denmark; 4Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark...

Cost–consequence analysis of fluticasone furoate/vilanterol 92/22 mcg for the management of COPD in the Spanish NHS

Cost-consequence analysis of fluticasone furoate/vilanterol 92/22 mcg for the management of COPD in the Spanish NHS Laura Amanda Vallejo-Aparicio,1 Germán Peces-Barba,2 Alicia Gil,3 Alicia Huerta Hernandez1 1Market Access, GlaxoSmithKline, Tres Cantos, Madrid, Spain; 2IIS-Fundación Jiménez Díaz. CIBERES, Madrid, Spain; 3Omakase Consulting, Barcelona, Spain Objectives: The Salford...

Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA

Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA Myrlene S Aigbogun,1 Sizhu Liu,2 Siddhesh A Kamat,1 Christophe Sapin,3 Amy M Duhig,2 Leslie Citrome4 1Health Economics and Outcomes Research, Otsuka Pharmaceutical Development and Commercialization, Inc, Princeton, NJ, USA; 2Global Health Economics and...

Impact of comorbidity on the risk and cost of hospitalization in HIV-infected patients: real-world data from Abruzzo Region

Impact of comorbidity on the risk and cost of hospitalization in HIV-infected patients: real-world data from Abruzzo Region Simona Cammarota,1 Anna Citarella,1 Lamberto Manzoli,2,3 Maria Elena Flacco,4 Giustino Parruti5 1LinkHealth s.r.l., Health Economics, Outcomes & Epidemiology, Naples, Italy; 2Department of Medicine Sciences, University of Ferrara, Ferrara, Italy; 3Regional...

Evaluation of statin utilization in the Republic of Macedonia during 2013–2016

Evaluation of statin utilization in the Republic of Macedonia during 20130-2016 Zorica Naumoska,1 Aleksandra K Nestorovska,1 Aleksandra Grozdanova,1 Kristina Hristova,2 Aleksandar Dimovski,1 Ljubica Suturkova,1 Zoran Sterjev1 1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, SS “Cyril and Methodius”, Skopje, Republic of Macedonia; 2Department of Health Insurance Fund...

Cost-effectiveness analysis of treating transplant-eligible multiple myeloma patients in Macedonia

Cost-effectiveness analysis of treating transplant-eligible multiple myeloma patients in Macedonia Vjollca Qerimi,1,2 Aleksandra Kapedanovska Nestorovska,1 Zoran Sterjev,1 Sonja Genadieva-Stavric,3 Ljubica Suturkova1 1Faculty of Pharmacy, Ss. Cyril and Methodius University in Skopje, Skopje, Macedonia; 2Institute of Public Health, Medical Decision Making and Health Technology...

A systematic literature review of the clinical and health economic burden of schizophrenia in privately insured patients in the United States

A systematic literature review of the clinical and health economic burden of schizophrenia in privately insured patients in the United States Wenjie Zhang,1 Tony B Amos,2 Stephen W Gutkin,1 Nicole Lodowski,1 Emma Giegerich,1 Kruti Joshi2 1WG US Advanced Health Analytics (WG AHA), Stamford, CT, USA; 2Janssen Scientific Affairs, LLC, Titusville, NJ, USA Purpose: The aim of this...

The cost of dysphagia in geriatric patients

The cost of dysphagia in geriatric patients Signe Westmark,1 Dorte Melgaard,1,2 Line O Rethmeier,3 Lars Holger Ehlers3 1Center for Clinical Research, North Denmark Regional Hospital, Hjørring, Denmark; 2Department of Physiotherapy and Occupational Therapy, North Denmark Regional Hospital, Hjørring, Denmark; 3Danish Center for Healthcare Improvements, Aalborg University, Aalborg...

Early introduction of a semi-elemental formula may be cost saving compared to a polymeric formula among critically ill patients requiring enteral nutrition: a cohort cost–consequence model

Early introduction of a semi-elemental formula may be cost saving compared to a polymeric formula among critically ill patients requiring enteral nutrition: a cohort cost-consequence model Alistair S Curry,1 Shkun Chadda,1 Aurélie Danel,2 Douglas L Nguyen3 1Health Economics, SIRIUS Market Access, London UK; 2Market Access, Nestlé Health Science, Vevey, Switzerland; 3University of...

A comparison between WHODAS 2.0 and Modified Barthel Index: which tool is more suitable for assessing the disability and the recovery rate in orthopedic rehabilitation?

A comparison between WHODAS 2.0 and Modified Barthel Index: which tool is more suitable for assessing the disability and the recovery rate in orthopedic rehabilitation? Tiziana Galli,1 Paolo Mirata,2 Emanuela Foglia,3 Davide Croce,3,4 Emanuele Porazzi,3 Lucrezia Ferrario,3 Elena Ricci,5 Elisabetta Garagiola,3 Roberta Pagani,3 Giuseppe Banfi6,7 1Department of Functional Recovery...

Claims-based proxies of patient instability among commercially insured adults with schizophrenia

Claims-based proxies of patient instability among commercially insured adults with schizophrenia Charles Ruetsch,1 Hyong Un,2 Heidi C Waters3 1Health Analytics, LLC, Columbia, MD, USA; 2Aetna, Inc, Blue Bell, PA, USA; 3Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA Objective: Schizophrenia (Sz) patients are among the highest utilizers of hospital...

Prevalence of antibiotic prescription in southern Italian outpatients: real-world data analysis of socioeconomic and sociodemographic variables at a municipality level

Prevalence of antibiotic prescription in southern Italian outpatients: real-world data analysis of socioeconomic and sociodemographic variables at a municipality level Veronica Russo,1,* Valeria Marina Monetti,1,* Francesca Guerriero,1 Ugo Trama,2 Antonella Guida,3 Enrica Menditto,1 Valentina Orlando1 1CIRFF, Center of Pharmacoeconomics, University of Naples Federico II...

Cost-effectiveness comparison of cabozantinib with everolimus, axitinib, and nivolumab in the treatment of advanced renal cell carcinoma following the failure of prior therapy in England

Cost-effectiveness comparison of cabozantinib with everolimus, axitinib, and nivolumab in the treatment of advanced renal cell carcinoma following the failure of prior therapy in England Jie Meng,1 Johanna Lister,1 Anne-Lise Vataire,2 Roman Casciano,1 Jerome Dinet2 1Analytica Laser, London, UK; 2Ipsen Pharma, Boulogne-Billancourt, France Purpose: The aim of this study was to...

Intermittent pneumatic compression is a cost-effective method of orthopedic postsurgical venous thromboembolism prophylaxis

Intermittent pneumatic compression is a cost-effective method of orthopedic postsurgical venous thromboembolism prophylaxis Rhodri Saunders,1 Anthony J Comerota,2 Audrey Ozols,3 Rafael Torrejon Torres,1 Kwok Ming Ho4 1Coreva Scientific, Freiburg, Germany; 2Jobst Vascular Institute, Toledo, OH, USA; 3Medtronic, Boulder, CO, USA; 4Royal Perth Hospital and School of Population...

The economic and clinical burden of early versus late initiation of celecoxib among patients with osteoarthritis

The economic and clinical burden of early versus late initiation of celecoxib among patients with osteoarthritis Ahmed Shelbaya,1,2 Caitlyn T Solem,3 Chris Walker,4 Yin Wan,3 Courtney Johnson,3 Joseph C Cappelleri1 1Pfizer Inc., New York, NY, 2Columbia School of Public Health, New York, NY, 3Pharmerit International, Bethesda, MD, USA; 4Pfizer Ltd., Tadworth, Surrey, UK Objective...

Clinical outcomes and health care utilization pre- and post-laparoscopic radiofrequency ablation of symptomatic fibroids and laparoscopic myomectomy: a randomized trial of uterine-sparing techniques (TRUST) in Canada

Clinical outcomes and health care utilization pre- and post-laparoscopic radiofrequency ablation of symptomatic fibroids and laparoscopic myomectomy: a randomized trial of uterine-sparing techniques (TRUST) in Canada Darrien D Rattray,1 Laura Weins,2 Lexy C Regush,2 James M Bowen,3,4 Daria O’Reilly,3,4 John A Thiel1,2 1Department of Gynecology, Regina General Hospital, Regina, SK...

Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals

Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals Purificación Martínez del Prado,1 Isabel Alvarez-López,2,3 Severina Domínguez-Fernández,4 Arrate Plazaola,5 Oliver Ibarrondo,6 Elena Galve-Calvo,1 Nerea Ancizar-Lizarraga,2,3 Mar...

Cost analysis of a growth guidance system compared with traditional and magnetically controlled growing rods for early-onset scoliosis: a US-based integrated health care delivery system perspective

Cost analysis of a growth guidance system compared with traditional and magnetically controlled growing rods for early-onset scoliosis: a US-based integrated health care delivery system perspective Scott J Luhmann,1–3 Eoin M McAughey,4 Stacey J Ackerman,5 David B Bumpass,6 Richard E McCarthy6 1Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis...

Cost analysis of pulmonary lobectomy procedure: comparison of stapler versus precision dissection and sealant [Corrigendum]

Cost analysis of pulmonary lobectomy procedure: comparison of stapler versus precision dissection and sealant [Corrigendum] On page 205, Acknowledgements section, “This research was funded by an unrestricted grant from Takeda Italia Spa. We are grateful for the collaboration and support of the Administration of Carlo Poma Hospital, Italy” should have been “We are grateful for the...

Modeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes

Modeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes EJ Gibson,1 N Begum,1 I Koblbauer,1 G Dranitsaris,2 D Liew,3 P McEwan,4 AA Tahami Monfared,5,6 Y Yuan,7 A Juarez-Garcia,7 D Tyas,8 M Lees9 1Wickenstones Ltd, Didcot, UK; 2Augmentium Pharma Consulting Inc, Toronto, ON, Canada; 3Department of Epidemiology and...

Clinical and economic burden of idiopathic pulmonary fibrosis in Quebec, Canada

Clinical and economic burden of idiopathic pulmonary fibrosis in Quebec, Canada Jean-Eric Tarride,1,2 Robert B Hopkins,1,2 Natasha Burke,1,2 Jason R Guertin,3,4 Daria O’Reilly,1,2 Charlene D Fell,5 Genevieve Dion,6 Martin Kolb7 1Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada; 2Programs for...